Disclosed is a recombinant BCG vaccine strain of Mycobacterium bovis that expresses the Sm14 antigen of Schistosoma mansoni (BCGr Pasteur ?LeuD/p?K410-hsp60*-Sm14). The vaccine strain according to the present invention is used for combating infection by parasites, particularly Schistosoma mansoni. The vaccine strain is a leucine-auxotrophic strain derived from the BCG substrain Pasteur, supplemented for leucine after genetic transformation with the construct p?K410-hsp60*-SM14. The effectiveness of the BCGr Pasteur ?LeuD/p?K410-hsp60*-Sm14 strain for combating Schistosoma mansoni infection by expressing the recombinant Sm14 antigen in vivo is demonstrated in the present invention.